Last update 21 Nov 2024

Bafisontamab

Overview

Basic Info

Drug Type
Bispecific antibody
Synonyms
Anti-egfr/anti-c-met bispecific antibody emb-01, Anti-egfr/c-met bispecific antibody emb-01, cMET/EGFR bispecific antibody (cancer)
+ [3]
Mechanism
EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists), c-Met inhibitors(Hepatocyte growth factor receptor inhibitors)
Originator Organization
Inactive Organization
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
---

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Gastrointestinal NeoplasmsPhase 2
CN
29 Jun 2022
Gastrointestinal NeoplasmsPhase 2
US
29 Jun 2022
Non-Small Cell Lung CancerPhase 2
CN
30 Jan 2022
Bile Duct NeoplasmsPhase 2
US
02 Dec 2021
Hepatocellular CarcinomaPhase 2
US
02 Dec 2021
Metastatic Digestive System Neuroendocrine Tumor G1Phase 2
US
21 Oct 2021
Metastatic Digestive System Neuroendocrine Tumor G1Phase 2
CN
21 Oct 2021
Smoking CessationPhase 2
US
19 May 2021
Tobacco Use DisorderPhase 2
US
19 May 2021
Colorectal CancerPhase 2
US
13 Dec 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
60
(dwiadbcinf) = 1.7% ingmxanxlb (imzdheozuz )
-
03 Apr 2022
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free